Product: FOLLISTATIN-344 - 1 MG
Manufacture: EUROLABS PEPTIDES
Quantity: 1 MG
0,00 € Shipping
0,00 € Total
Sibutril (Sibutramine,Sibus, Biomag,...
Product: Sibutramine Sterling 20mg...
One vial of 10ml (250mg/ml) Company -...
Dark Labs CRACK Pre-WorkoutCRACK by...
Combo contain 1x Azitro + 1x...
Bensedin (Diazepam) 10mg...
What does Parabolic...
Dek pharma 50mg/50 tabs
Manufacturer: Roche Substance:...
Category Buy Injectable...
Product: ZOLPIDEM Manufacturer:...
Manufacturer: Bio PharmaSubstance:...
Product: SUPER PCTManufacture:...
Product: EVOKE Ultimate Testosterone...
FOLLISTATIN-344 - 1 MG | EUROLABS PEPTIDES
Introduction- Description and Benefits
Follistatin is a secreted glycoprotein initially identified as an activin competitor known for its FSH (follicle stimulating hormone) impeding property in ovarian follicular fluid. In addition to this, it can block the activity of TGF beta ligands including myostatin, GDF-11. Recombinant human follistatin is a protein containing 344 amino acids. Its mechanism of action is to increase muscle growth and mass by blocking myostatin that is concerned with restricting muscle growth.
Why Body builders should go for Follistatin-344?
This drug quickly gained admiration in the field of bodybuilding because of its ability to increase lean tissue mass. Myostatin essentially plays a role in regulating skeletal muscle fibrosis. As high concentration of myostatin is unfavorable for adequate tissue function, it causes diseases in organs and bone marrow. Follistatin helps in revitalizing tissues and aids athletes to get excellent muscle mass without regular exercise and workout. It has a typical anti-ageing property and contributes in muscle growth by hyperplasia and activated hypertrophy.
FOLLISTATIN-344 – Dosage and duration of course
FOLLISTATIN-344- Storage protocols
FOLLISTATIN-344- Administration protocols
FOLLISTATIN-344- Drug combination
FOLLISTATIN-344- Side effects
Effects related to that product:
There are many beneficial effects related to that product but few of them are given below: